When patients with rheumatoid arthritis fail tumour necrosis factor inhibitors: what is the next step?
- PMID: 18854512
- DOI: 10.1136/ard.2008.098111
When patients with rheumatoid arthritis fail tumour necrosis factor inhibitors: what is the next step?
Comment on
-
IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial.Ann Rheum Dis. 2008 Nov;67(11):1516-23. doi: 10.1136/ard.2008.092932. Epub 2008 Jul 14. Ann Rheum Dis. 2008. PMID: 18625622 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
